Greenphire Announces New London Office to Facilitate Expansion in Europe
Greenphire
, the leading provider of payment technologies for the clinical trials industry, today announced an expansion into the European market with the opening of its London office. This addition is a key part of the 2013 strategic plan and isdesigned to support the increasing global demand for Greenphire’s products and services.
The expansion reflects the commercial and operational success Greenphire has enjoyed in the last two years. Both global payment technology platforms for Patient and Investigator payments have seen increased adoption within the life sciences industry and the new office in London will play a critical role in continuing to build on the growth Greenphire has experienced.
Sam Whitaker, Founder and CEO, comments “We are excited to execute on this key part of our 2013 strategic plan. Establishing our presence in Europe allows us to support our Enterprise clients in those areas where they conduct research and development, facilitates stronger support of the many clinical investigators conducting research on behalf of biopharmaceutical companies and provides abase from which we can grow our commercial presence in Europe.”
The new UK office address is: Greenphire, 1 EastPoultry Avenue, London, EC1A 9PT, United Kingdom and the London office number is: +44 (0) 208 150 6470
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
